In addition to the effects on KCs, geniposide and chlorogenic acid have also been reported to improve NAFLD by upregulating the expression of PPAR-α [29] and GLP-1R [30] in hepatocytes. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.